Eledon Pharmaceuticals, Inc. (ELDN): Shares Outstanding
75.43M
As of 2025-12-31
80.89M
As of 2026-06-30
+76.3%
3-year compound annual growth
+37.8%
5-year compound annual growth
+12.8%
10-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 75.43M | +26.2% | 2026-03-19, Balance as of period end |
| 2024-12-31 | 59.79M | +146.9% | 2026-03-19, Balance as of period end |
| 2023-12-31 | 24.21M | +75.8% | 2025-08-14, Balance as of period end |
| 2022-12-31 | 13.78M | -3.7% | 2024-08-19, Balance as of period end |
| 2021-12-31 | 14.31M | -5.6% | 2023-03-30, Balance as of period end |
| 2020-12-31 | 15.16M | n/m | 2022-03-24, Balance as of period end |
| 2019-12-31 | 720.4K | -92.4% | 2021-03-31, Balance as of period end |
| 2018-12-31 | 9.42M | +32.5% | 2020-03-17, Balance as of period end |
| 2017-12-31 | 7.11M | n/m | 2019-03-28, Balance as of period end |
| 2016-12-31 | 394.3K | -98.3% | 2018-04-02, Balance as of period end |
| 2015-12-31 | 22.60M | +1.0% | 2017-03-03, Balance as of period end |
| 2014-12-31 | 22.38M | n/m | 2016-03-10, Balance as of period end |
| 2013-12-31 | 493.3K | n/a | 2015-03-26, Balance as of period end |